In conclusion, we developed and characterized eight novel PDX from breast cancer brain metastases from ER+, HER2+, and TN subtypes, derived a matching cell line from one TN BM-PDX and demonstrated their brain metastatic potential. Here, ESR1 is linked to breast carcinoma.